Miller Investment Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $285K | Hold |
3,435
| – | – | 0.03% | 89 |
|
2025
Q1 | $279K | Hold |
3,435
| – | – | 0.03% | 90 |
|
2024
Q4 | $309K | Hold |
3,435
| – | – | 0.03% | 90 |
|
2024
Q3 | $339K | Sell |
3,435
-3,140
| -48% | -$310K | 0.04% | 89 |
|
2024
Q2 | $610K | Hold |
6,575
| – | – | 0.07% | 75 |
|
2024
Q1 | $624K | Hold |
6,575
| – | – | 0.08% | 78 |
|
2023
Q4 | $587K | Hold |
6,575
| – | – | 0.08% | 79 |
|
2023
Q3 | $480K | Hold |
6,575
| – | – | 0.08% | 75 |
|
2023
Q2 | $547K | Hold |
6,575
| – | – | 0.08% | 74 |
|
2023
Q1 | $501K | Hold |
6,575
| – | – | 0.08% | 74 |
|
2022
Q4 | $546K | Hold |
6,575
| – | – | 0.09% | 72 |
|
2022
Q3 | $522K | Hold |
6,575
| – | – | 0.11% | 65 |
|
2022
Q2 | $488K | Hold |
6,575
| – | – | 0.1% | 67 |
|
2022
Q1 | $591K | Sell |
6,575
-386
| -6% | -$34.7K | 0.09% | 63 |
|
2021
Q4 | $779K | Buy |
6,961
+3,573
| +105% | +$400K | 0.11% | 58 |
|
2021
Q3 | $426K | Sell |
3,388
-4,688
| -58% | -$589K | 0.07% | 70 |
|
2021
Q2 | $1.09M | Hold |
8,076
| – | – | 0.19% | 45 |
|
2021
Q1 | $1.1M | Hold |
8,076
| – | – | 0.2% | 44 |
|
2020
Q4 | $1.14M | Hold |
8,076
| – | – | 0.21% | 42 |
|
2020
Q3 | $900K | Hold |
8,076
| – | – | 0.22% | 41 |
|
2020
Q2 | $904K | Buy |
8,076
+1,300
| +19% | +$146K | 0.27% | 40 |
|
2020
Q1 | $525K | Hold |
6,776
| – | – | 0.17% | 48 |
|
2019
Q4 | $644K | Hold |
6,776
| – | – | 0.14% | 50 |
|
2019
Q3 | $517K | Hold |
6,776
| – | – | 0.12% | 54 |
|
2019
Q2 | $594K | Hold |
6,776
| – | – | 0.14% | 52 |
|
2019
Q1 | $613K | Sell |
6,776
-3,388
| -33% | -$307K | 0.16% | 50 |
|
2018
Q4 | $729K | Hold |
10,164
| – | – | 0.21% | 43 |
|
2018
Q3 | $974K | Hold |
10,164
| – | – | 0.3% | 40 |
|
2018
Q2 | $968K | Buy |
+10,164
| New | +$968K | 0.29% | 41 |
|